ID
12912
Description
A Study of the Safety and Effectiveness of Galantamine Versus Placebo in the Treatment of Patients With Vascular Dementia or Mixed Dementia; ODM derived from: https://clinicaltrials.gov/show/NCT00261573
Link
https://clinicaltrials.gov/show/NCT00261573
Keywords
Versions (1)
- 1/6/16 1/6/16 -
Copyright Holder
CC BY-NC 3.0
Uploaded on
January 6, 2016
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Alzheimer Disease NCT00261573
Eligibility Alzheimer Disease NCT00261573
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Parkinson's disease
Data type
boolean
Alias
- UMLS CUI [1]
- C0030567
Description
cognitive impairment
Data type
boolean
Alias
- UMLS CUI [1]
- C0392335
Description
Comorbidity
Data type
boolean
Alias
- UMLS CUI [1]
- C0009488
Description
history of epilepsy, convulsions, drug abuse or alcohol abuse
Data type
boolean
Alias
- UMLS CUI [1]
- C0014544
- UMLS CUI [2]
- C0036572
- UMLS CUI [3]
- C0038586
Description
child bearing potential
Data type
boolean
Alias
- UMLS CUI [1]
- C0700589
Similar models
Eligibility Alzheimer Disease NCT00261573
- StudyEvent: Eligibility
C3539026 (UMLS CUI [2])
C0036572 (UMLS CUI [2])
C0038586 (UMLS CUI [3])